Multi-drug carbapenem-resistant Klebsiella pneumoniae infection carrying the OXA-48 gene and showing variations in outer membrane protein 36 causing an outbreak in a tertiary care hospital in Riyadh, Saudi Arabia

International Journal of Infectious Diseases

Volumn 28, Issue , 2014, Pages 186-192

  uz Zaman, Taher ^a   Aldrees, Mohammed ^a   Al Johani, Sameera M ^a,b   Alrodayyan, Maha ^a   Aldughashem, Faizah A ^b   Balkhy, Hanan H ^a,b  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

Carbapenem resistance; Extended spectrum beta lactamases; Klebsiella pneumoniae; Outer membrane protein; Saudi Arabia

Indexed keywords

AMIKACIN; BETA LACTAMASE TEM 1; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE; OUTER MEMBRANE PROTEIN; OXACILLINASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; KLEBSIELLA PNEUMONIAE INFECTION; MULTILOCUS SEQUENCE TYPING; OXA 48 GENE; PREMATURITY; SAUDI ARABIA; STOP CODON; TERTIARY CARE CENTER; TRANSPOSON; BACTERIAL GENE; CHEMISTRY; DRUG EFFECTS; EPIDEMIC; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BETA-LACTAMASES; CARBAPENEMS; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; GENETIC VARIATION; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; SAUDI ARABIA; TERTIARY CARE CENTERS;

EID: 84922824418     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.05.021     Document Type: Article

References (38)

1. Yigit H., Queenan A.M., Anderson G.J., Domenech-Sanchez A., Biddle J.W., Steward C.D., et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001, 45:1151-1161.
2. Bradford P.A., Bratu S., Urban C., Visalli M., Mariano N., Landman D., et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis 2004, 39:55-60.
3. Garcia-Fernandez A., Miriagou V., Papagiannitsis C.C., Giordano A., Venditti M., Mancini C., et al. An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant. Antimicrob Agents Chemother 2010, 54:4178-4184.
4. Livermore D.M. Has the era of untreatable infections arrived?. J Antimicrob Chemother 2009, 64(Suppl 1):i29-i36.
5. Cuzon G., Ouanich J., Gondret R., Naas T., Nordmann P. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother 2011, 55:2420-2423.
6. Livermore D.M. Current epidemiology and growing resistance of Gram-negative pathogens. Korean J Intern Med 2012, 27:128-142.
7. Yang D., Guo Y., Zhang Z. Combined porin loss and extended spectrum beta-lactamase production is associated with an increasing imipenem minimal inhibitory concentration in clinical Klebsiella pneumoniae strains. Curr Microbiol 2009, 58:366-370.
8. Lee K., Yong D., Choi Y.S., Yum J.H., Kim J.M., Woodford N., et al. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss. Int J Antimicrob Agents 2007, 29:201-206.
9. Dutzler R., Rummel G., Alberti S., Hernandez-Alles S., Phale P., Rosenbusch J., et al. Crystal structure and functional characterization of OmpK36, the osmoporin of Klebsiella pneumoniae. Structure 1999, 7:425-434.
10. Simonet V., Mallea M., Pages J.M. Substitutions in the eyelet region disrupt cefepime diffusion through the Escherichia coli OmpF channel. Antimicrob Agents Chemother 2000, 44:311-315.
11. De E., Basle A., Jaquinod M., Saint N., Mallea M., Molle G., et al. A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin. Mol Microbiol 2001, 41:189-198.
12. Zhang R., Wang X.D., Cai J.C., Zhou H.W., Lv H.X., Hu Q.F., et al. Outbreak of Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae with high qnr prevalence in a Chinese hospital. J Med Microbiol 2011, 60:977-982.
13. Balkhy H.H., El-Saed A., Al Johani S.M., Francis C., Al-Qahtani A.A., Al-Ahdal M.N., et al. The epidemiology of the first described carbapenem-resistant Klebsiella pneumoniae outbreak in a tertiary care hospital in Saudi Arabia: how far do we go?. Eur J Clin Microbiol Infect Dis 2012, 31:1901-1909.
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100-17. CLSI; 2007.
15. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement. CLSI; 2010.
16. Cohen Stuart J., Leverstein-Van Hall M.A. Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents 2010, 36:205-210.
17. Diancourt L., Passet V., Verhoef J., Grimont P.A., Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005, 43:4178-4182.
18. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596-1599.
19. Queenan A.M., Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007, 20:440-458.
20. Pitout J.D., Hossain A., Hanson N.D. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol 2004, 42:5715-5721.
21. Mathers A.J., Hazen K.C., Carroll J., Yeh A.J., Cox H.L., Bonomo R.A., et al. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world. J Clin Microbiol 2013, 51:680-683.
22. Pitart C., Sole M., Roca I., Fabrega A., Vila J., Marco F. First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 beta-lactamase in Klebsiella pneumoniae in Spain. Antimicrob Agents Chemother 2011, 55:4398-4401.
23. Stolle I., Prenger-Berninghoff E., Stamm I., Scheufen S., Hassdenteufel E., Guenther S., et al. Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs. J Antimicrob Chemother 2013, 68:2802-2808.
24. Al-Qahtani A.A., Al-Agamy M.H., Ali M.S., Al-Ahdal M.N., Aljohi M.A., Shibl A.M. Characterization of extended-spectrum beta lactamase-producing Klebsiella pneumoniae from Riyadh, Saudi Arabia. J Chemother 2014, 26:139-145.
25. Kaczmarek F.M., Dib-Hajj F., Shang W., Gootz T.D. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob Agents Chemother 2006, 50:3396-3406.
26. Chia J.H., Su L.H., Lee M.H., Kuo A.J., Shih N.Y., Siu L.K., et al. Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure. Microb Drug Resist 2010, 16:317-325.
27. Huang H., Hancock R.E. The role of specific surface loop regions in determining the function of the imipenem-specific pore protein OprD of Pseudomonas aeruginosa. J Bacteriol 1996, 178:3085-3090.
28. Tsai Y.K., Fung C.P., Lin J.C., Chen J.H., Chang F.Y., Chen T.L., et al. Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob Agents Chemother 2011, 55:1485-1493.
29. Mena A., Plasencia V., Garcia L., Hidalgo O., Ayestaran J.I., Alberti S., et al. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol 2006, 44:2831-2837.
30. Wang X.D., Cai J.C., Zhou H.W., Zhang R., Chen G.X. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency. J Med Microbiol 2009, 58:1196-1202.
31. Lou H., Chen M., Black S.S., Bushell S.R., Ceccarelli M., Mach T., et al. Altered antibiotic transport in OmpC mutants isolated from a series of clinical strains of multi-drug resistant E. coli. PLoS One 2011, 6:e25825.
32. Findlay J., Hamouda A., Dancer S.J., Amyes S.G. Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy. Clin Microbiol Infect 2012, 18:140-146.
33. Paulin-Curlee G.G., Singer R.S., Sreevatsan S., Isaacson R., Reneau J., Foster D., et al. Genetic diversity of mastitis-associated Klebsiella pneumoniae in dairy cows. J Dairy Sci 2007, 90:3681-3689.
34. Hindiyeh M., Smollen G., Grossman Z., Ram D., Davidson Y., Mileguir F., et al. Rapid detection of blaKPC carbapenemase genes by real-time PCR. J Clin Microbiol 2008, 46:2879-2883.
35. Hujer K.M., Hujer A.M., Hulten E.A., Bajaksouzian S., Adams J.M., Donskey C.J., et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 2006, 50:4114-4123.
36. Poirel L., Héritier C., Tolün V., Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004, 48:15-22.
37. Paterson D.L., Hujer K.M., Hujer A.M., Yeiser B., Bonomo M.D., Rice L.B., et al. Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases. Antimicrob Agents Chemother 2003, 47:3554-3560.
38. Edelstein M., Pimkin M., Palagin I., Edelstein I., Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 2003, 47:3724-3732.